myLaminin Perspectives

Image shows a healthcare professional administering a vaccine to a young child.

ICH E6 (R3) Is Reshaping Clinical Trials. Here’s What Sponsors, CROs, and Research Sites Need to Know

Learn how ICH E6 (R3) is reshaping clinical trials through risk-based quality management, decentralized research oversight, data integrity, and continuous inspection readiness across global clinical research operations.

Deanne Bassili

5 days ago5 min read

ICH E6 (R3) Is Here: What It Actually Means for Clinical Trials and Why It Matters Now

ICH E6 (R3) is reshaping clinical trial compliance across Canada, the U.S., EU, UK, and Australia. The updated Good Clinical Practice (GCP) guideline emphasizes Quality by Design, proactive risk management, audit trail traceability, sponsor oversight, informed consent, data integrity, and inspection readiness. myLaminin helps research teams and sponsors manage multi-site clinical trials with real-time oversight, CTQ monitoring, compliant eConsent, secure audit trails, and val

Deanne Bassili

May 74 min read